Loop Diuretics Market Highlights 2022-2030
The loop diuretics market is estimated to garner a sizeable revenue by growing with a CAGR of ~7% during the forecast period, i.e., 2022-2030. The growth of the market can be attributed to the growing prevalence of hypertension across the world as a result of large number of incidences of high blood pressure. Moreover, changing lifestyles and eating habits are also causing lifestyle-related diseases and several other chronic disorders, which is another factor expected to drive market growth in the coming years. According to the United Nations organization, the total number of deaths due to chronic diseases are expected to rise up to70% by 2030. The global of the burden is calculated to increase up to 56%. The demand for the loop diuretic market is also anticipated to rise significantly in the near future owing to the advancements in technology, growing cases of renal diseases, and increasing geriatric population globally. Along with these, increase in patient population and absence of appropriate treatment are evaluated to act as opportunities for market growth.
The market is segmented based on indication into diabetes insipidus, edema, hypercalciuria, hypertension, and others, out of which, the hypertension segment is anticipated to grab the largest share by the end of 2029 on account of increasing occurrence of high blood pressure among the global population and rising number of people following a sedentary lifestyle. Furthermore, on the basis of route of administration, the oral segment in the global loop diuretics market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that oral administration of a medicine is one of the most convenient, and usually the safest and least expensive method as compared to other ways of drug administration. CLICK TO DOWNLOAD SAMPLE REPORT
Major Macro-Economic Indicators Impacting the Market Growth
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Global Loop Diuretics Market Regional Synopsis
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the increasing prevalence of chronic diseases due to pollution and growing geriatric population in the region. Furthermore, the market in North America is evaluated to occupy the largest share in terms of revenue during the forecast period, owing to detrimental lifestyle changes and presence of leading healthcare service providers in the region. Along with this, North America also leads in terms of research and development of advanced loop diuretics, which is also expected to contribute to the market growth in the region. As per the analysis of Centres for Disease Control and Prevention, the top ten health problems in America are heart disease, cancer, stroke, respiratory disease, injuries, diabetes, Alzheimer's disease, influenza and pneumonia, kidney disease, and septicaemia.
The global loop diuretics market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Market Segmentation
Our in-depth analysis of the global loop diuretics market includes the following segments:
By Indication
- Diabetes Insipidus
- Edema
- Hypercalciuria
- Hypertension
- Others
By Drugs
- Furosemide
- Ethacrynic Acid
- Torsemide
- Bumetanide
- Others
By Route of Administration
- Oral
- Intravenous
Growth Drivers
- Increasing Geriatric Population Worldwide
- Rising Prevalence of Chronic Diseases
Challenges
- Side-Effects Associated with the Use of Loop Diuretics Drugs
Top Featured Companies Dominating the Market
- Pfizer Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck & Co.
- Meda Manufacturing GmbH
- GlaxoSmithKline plc
- F. Hoffmann-La Roche Ltd
- Cipla Ltd
- Endo International plc
- Hikma Pharmaceuticals Inc.
- Teva Pharmaceuticals Industries Ltd
- Novartis AG
